Literature DB >> 20890245

Use of fundus autofluorescence images to predict geographic atrophy progression.

Srilaxmi Bearelly1, Aziz A Khanifar, David E Lederer, Jane J Lee, Jason H Ghodasra, Sandra S Stinnett, Scott W Cousins.   

Abstract

PURPOSE: Fundus autofluorescence imaging has been shown to be helpful in predicting progression of geographic atrophy (GA) secondary to age-related macular degeneration. We assess the ability of fundus autofluorescence imaging to predict rate of GA progression using a simple categorical scheme.
METHODS: Subjects with GA secondary to age-related macular degeneration with fundus autofluorescence imaging acquired at least 12 months apart were included. Rim area focal hyperautofluorescence was defined as percentage of the 500-μm-wide margin bordering the GA that contained increased autofluorescence. Rim area focal hyperautofluorescence on baseline fundus autofluorescence images was assessed and categorized depending on the extent of rim area focal hyperautofluorescence (Category 1: ≤33%; Category 2: between 33 and 67%; Category 3: ≥67%). Total GA areas at baseline and follow-up were measured to calculate change in GA progression.
RESULTS: Forty-five eyes of 45 subjects were included; average duration of follow-up was 18.5 months. Median growth rates differed among categories of baseline rim area focal hyperautofluorescence (P = 0.01 among Categories 1, 2, and 3; P = 0.008 for Category 1 compared with Category 3, Jonckheere-Terpstra test).
CONCLUSION: A simple categorical scheme that stratifies the amount of increased autofluorescence in the 500-μm margin bordering GA may be used to differentiate faster and slower progressors.

Entities:  

Mesh:

Year:  2011        PMID: 20890245      PMCID: PMC3040508          DOI: 10.1097/IAE.0b013e3181e0958b

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  16 in total

1.  Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration.

Authors:  F G Holz; C Bellman; S Staudt; F Schütt; H E Völcker
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-04       Impact factor: 4.799

2.  Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration.

Authors:  A Bindewald; S Schmitz-Valckenberg; J J Jorzik; J Dolar-Szczasny; H Sieber; C Keilhauer; A W A Weinberger; S Dithmar; D Pauleikhoff; U Mansmann; S Wolf; F G Holz
Journal:  Br J Ophthalmol       Date:  2005-07       Impact factor: 4.638

3.  Predictive value of fundus autofluorescence for development of geographic atrophy in age-related macular degeneration.

Authors:  John Chopin Hwang; Jackie W K Chan; Stanley Chang; R Theodore Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

4.  Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD.

Authors:  Steffen Schmitz-Valckenberg; Almut Bindewald-Wittich; Joanna Dolar-Szczasny; Jens Dreyhaupt; Sebastian Wolf; Hendrik P N Scholl; Frank G Holz
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

5.  The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials.

Authors:  Janet S Sunness; Eyal Margalit; Divya Srikumaran; Carol A Applegate; Yan Tian; Daniel Perry; Barbara S Hawkins; Neil M Bressler
Journal:  Ophthalmology       Date:  2007-02       Impact factor: 12.079

6.  Complement activation by photooxidation products of A2E, a lipofuscin constituent of the retinal pigment epithelium.

Authors:  Jilin Zhou; Young Pyo Jang; So Ra Kim; Janet R Sparrow
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-23       Impact factor: 11.205

7.  Changes in fundus autofluorescence in patients with age-related maculopathy. Correlation to visual function: a prospective study.

Authors:  Wilma Einbock; Andreas Moessner; Ute E K Schnurrbusch; Frank G Holz; Sebastian Wolf
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-10-13       Impact factor: 3.117

8.  Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.

Authors:  J S Sunness; J Gonzalez-Baron; C A Applegate; N M Bressler; Y Tian; B Hawkins; Y Barron; A Bergman
Journal:  Ophthalmology       Date:  1999-09       Impact factor: 12.079

9.  Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration.

Authors:  Frank G Holz; Almut Bindewald-Wittich; Monika Fleckenstein; Jens Dreyhaupt; Hendrik P N Scholl; Steffen Schmitz-Valckenberg
Journal:  Am J Ophthalmol       Date:  2006-12-22       Impact factor: 5.258

10.  The lipofuscin fluorophore A2E perturbs cholesterol metabolism in retinal pigment epithelial cells.

Authors:  Aparna Lakkaraju; Silvia C Finnemann; Enrique Rodriguez-Boulan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-19       Impact factor: 11.205

View more
  20 in total

Review 1.  Fundus autofluorescence imaging in dry AMD: 2014 Jules Gonin lecture of the Retina Research Foundation.

Authors:  Frank G Holz; Julia S Steinberg; Arno Göbel; Monika Fleckenstein; Steffen Schmitz-Valckenberg
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-19       Impact factor: 3.117

2.  Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration.

Authors:  Marcela Marsiglia; Sucharita Boddu; Srilaxmi Bearelly; Luna Xu; Barry E Breaux; K Bailey Freund; Lawrence A Yannuzzi; R Theodore Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-08       Impact factor: 4.799

3.  Predictors for the progression of geographic atrophy in patients with age-related macular degeneration: fundus autofluorescence study with modified fundus camera.

Authors:  Y J Jeong; I H Hong; J K Chung; K L Kim; H K Kim; S P Park
Journal:  Eye (Lond)       Date:  2014-01-24       Impact factor: 3.775

4.  Fundus autofluorescence imaging: Fundamentals and clinical relevance.

Authors:  Yasir J Sepah; Abeer Akhtar; Mohammad Ali Sadiq; Yamama Hafeez; Humzah Nasir; Brian Perez; Narissa Mawji; Diana J Dean; Daniel Ferraz; Quan Dong Nguyen
Journal:  Saudi J Ophthalmol       Date:  2014-03-24

5.  VISUALIZING RETINAL PIGMENT EPITHELIUM PHENOTYPES IN THE TRANSITION TO GEOGRAPHIC ATROPHY IN AGE-RELATED MACULAR DEGENERATION.

Authors:  Emma C Zanzottera; Thomas Ach; Carrie Huisingh; Jeffrey D Messinger; Richard F Spaide; Christine A Curcio
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

Review 6.  Investigational Agents in Development for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration.

Authors:  Hannah J Yu; Charles C Wykoff
Journal:  BioDrugs       Date:  2021-04-24       Impact factor: 5.807

7.  Outer Retinal Thickness and Fundus Autofluorescence in Geographic Atrophy.

Authors:  Diane L Wang; Julia Agee; Marco Mazzola; Riccardo Sacconi; Giuseppe Querques; Alan D Weinberg; R Theodore Smith
Journal:  Ophthalmol Retina       Date:  2019-08-07

8.  Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11.

Authors:  Amitha Domalpally; Ronald Danis; Elvira Agrón; Barbara Blodi; Traci Clemons; Emily Chew
Journal:  Ophthalmology       Date:  2016-07-19       Impact factor: 12.079

9.  Histologic basis of variations in retinal pigment epithelium autofluorescence in eyes with geographic atrophy.

Authors:  Martin Rudolf; Susan D Vogt; Christine A Curcio; Carrie Huisingh; Gerald McGwin; Anna Wagner; Salvatore Grisanti; Russell W Read
Journal:  Ophthalmology       Date:  2013-01-26       Impact factor: 12.079

Review 10.  CLINICAL ENDPOINTS FOR THE STUDY OF GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION.

Authors:  SriniVas R Sadda; Usha Chakravarthy; David G Birch; Giovanni Staurenghi; Erin C Henry; Christopher Brittain
Journal:  Retina       Date:  2016-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.